Cleveland Clinic released its list of the top 10 medical innovations it believes will change health care next year, including gene therapy for blood disorders, a new class of medications for cystic fibrosis and increased access to telemedicine, according to a news release.

The annual list, which is selected by a panel of Clinic researchers and clinicians, was announced in conjunction with the system's 18th annual Medical Innovation Summit, which was held virtually on Tuesday, Oct. 6.

The committee of experts that selected the breakthrough technologies was led by Dr. Will Morris, executive medical director for Cleveland Clinic Innovations (the system's development and commercialization arm), and Dr. Akhil Saklecha, managing director of Cleveland Clinic Ventures, which was formed three years ago to invest in emerging health care companies that can deliver financial returns to the Clinic.

The Clinic also announced that it will present a new award at next year's summit to a team, organization or individual who has made a significant contribution to health care delivery with a focus on one or more defined areas, according to the release, which notes that details will be released early next year.

Below are the Clinic's top 10 medical innovations for 2021, in order of importance, according to the release:

Read more:
Cleveland Clinic unveils top 10 medical innovations for 2021 - Crain's Cleveland Business

Comments are closed.